- Home
- SHMD vs ORMP Comparison
SHMD vs ORMP Comparison
Compare SHMD & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHMD | ORMP |
|---|---|---|
| Founded | 1864 | 2002 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 197.6M |
| IPO Year | 2023 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SHMD | ORMP |
|---|---|---|
| Price | $4.42 | $4.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 136.9K |
| Earning Date | 05-15-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 5.35% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $49.82 | N/A |
| Revenue Next Year | $36.39 | N/A |
| P/E Ratio | ★ N/A | $1.70 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $2.34 | $2.09 |
| 52 Week High | $10.65 | $5.47 |
Technical Indicators
Market Signals| Indicator | SHMD | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 67.93 | 45.98 |
| Support Level | $4.78 | $4.54 |
| Resistance Level | $7.36 | $5.01 |
| Average True Range (ATR) | 0.40 | 0.13 |
| MACD | 0.21 | -0.02 |
| Stochastic Oscillator | 88.66 | 30.56 |
Price Performance
Historical ComparisonAbout SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.